Harnessing artificial intelligence and machine learning to develop novel therapies
Current drug discovery efforts require significant time-consuming manual efforts to search literature, publications, and presentations to identify connections between genes, pathways, molecular targets, and drugs. Such efforts require searching through disparate databases and using search engines with poor understanding of the life sciences language, leading researchers to have an incomplete understanding of all the connections and interactions between biological entities.
We believe that harnessing artificial intelligence and machine learning will allow us to overcoming these challenges and significantly increasing the chances of success while reducing the time and money spent.
This is why we have partnered with Innoplexus, a global champion in the field of Artificial Intelligence for Life Sciences.
Innoplexus is a leading global AI-based platform for drug discovery and development with over 100 patent applications including 21 grants in artificial intelligence, machine learning, and blockchain technologies. Innoplexus' solutions can generate real-time insights from hundreds of terabytes of structured and unstructured private and public life science data by rendering it searchable for context; thereby facilitating virtual drug discovery with continuous, objective and informed decision-making at an unprecedented speed.
